Search results: Sage Journals

Restricted accessResearch articleFirst published June, 2026

Allostatic Load in Patients with Type 2 Diabetes Treated with GLP-1 Receptor Agonists

Yang Yu, Susan Groth

Metabolic Syndrome and Related Disorders

Open accessReview articleFirst published 2022

The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practice

Bernt Johan von Scholten, Frederik Flindt Kreiner, Søren Rasmussen [...]

Therapeutic Advances in Endocrinology and Metabolism

Free accessReview articleFirst published May, 2018

The role of basal insulin and GLP-1 receptor agonist combination products in the management of type 2 diabetes

Taylor R. Inman, Erika Plyushko, Nicholas P. Austin [...]

Therapeutic Advances in Endocrinology and Metabolism

Free accessResearch articleFirst published March, 2017

Treatment Outcomes and Tolerability Following Initiation of GLP-1 Receptor Agonists Among Type 2 Diabetes Patients in Primary Care Practices in Germany

Qing Qiao, Kristina Johnsson, Susan Grandy [...]

Journal of Diabetes Science and Technology

Restricted accessResearch articleFirst published May 6, 2008

Exogenous Glucagon-Like Peptide-2 (GLP-2) Augments GLP-2 Receptor mRNA and Maintains Proglucagon mRNA Levels in Resected Rats

Matthew C. Koopmann, David W. Nelson, Sangita G. Murali [...]

Journal of Parenteral and Enteral Nutrition

Restricted accessResearch articleFirst published November, 2025

Preoperative GLP-1 Receptor Agonist Use and Postoperative Outcomes Following Operative Ankle Fracture Repair in Patients With Type 2 Diabetes: A National Database Study

Carter J.K. White, Ankit Choudhury, Harshavardhan Bollepalli [...]

Foot & Ankle International

Open accessResearch articleFirst published 2019

Simultaneous analyses of carbohydrate-mediated serum GLP-1 and GLP-2 and duodenal receptor expression in children with and without celiac disease

Marianna Rachmiel, Gilad Ben-Yehudah, Haim Shirin [...]

Therapeutic Advances in Gastroenterology

Open accessResearch articleFirst published July, 2023

Expected Health Benefits of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Older Adults

Rahul S. Dadwani, Wen Wan, M. Reza Skandari [...]

MDM Policy & Practice

Open accessResearch articleFirst published November 22, 2022

Glucose and Several Mitogenic Agents Modulate the Glucagon-Like Peptide-2 Receptor Expression in Cultured Rat Astrocytes

Esther Velázquez, Yannick Le Baut Ayuso, Enrique Blázquez [...]

Journal of Alzheimer's Disease Reports

Free accessResearch articleFirst published September, 2024

Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis

Maria-Ioanna Stefanou, Aikaterini Theodorou, Konark Malhotra [...]

European Stroke Journal

Restricted accessResearch articleFirst published June, 2026

Allostatic Load in Patients with Type 2 Diabetes Treated with GLP-1 Receptor Agonists

Yang Yu, Susan Groth

Metabolic Syndrome and Related Disorders

Open accessReview articleFirst published 2022

The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practice

Bernt Johan von Scholten, Frederik Flindt Kreiner, Søren Rasmussen [...]

Therapeutic Advances in Endocrinology and Metabolism

Free accessReview articleFirst published May, 2018

The role of basal insulin and GLP-1 receptor agonist combination products in the management of type 2 diabetes

Taylor R. Inman, Erika Plyushko, Nicholas P. Austin [...]

Therapeutic Advances in Endocrinology and Metabolism

Free accessResearch articleFirst published March, 2017

Treatment Outcomes and Tolerability Following Initiation of GLP-1 Receptor Agonists Among Type 2 Diabetes Patients in Primary Care Practices in Germany

Qing Qiao, Kristina Johnsson, Susan Grandy [...]

Journal of Diabetes Science and Technology

Restricted accessResearch articleFirst published May 6, 2008

Exogenous Glucagon-Like Peptide-2 (GLP-2) Augments GLP-2 Receptor mRNA and Maintains Proglucagon mRNA Levels in Resected Rats

Matthew C. Koopmann, David W. Nelson, Sangita G. Murali [...]

Journal of Parenteral and Enteral Nutrition

Restricted accessResearch articleFirst published November, 2025

Preoperative GLP-1 Receptor Agonist Use and Postoperative Outcomes Following Operative Ankle Fracture Repair in Patients With Type 2 Diabetes: A National Database Study

Carter J.K. White, Ankit Choudhury, Harshavardhan Bollepalli [...]

Foot & Ankle International

Open accessResearch articleFirst published 2019

Simultaneous analyses of carbohydrate-mediated serum GLP-1 and GLP-2 and duodenal receptor expression in children with and without celiac disease

Marianna Rachmiel, Gilad Ben-Yehudah, Haim Shirin [...]

Therapeutic Advances in Gastroenterology

Open accessResearch articleFirst published July, 2023

Expected Health Benefits of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Older Adults

Rahul S. Dadwani, Wen Wan, M. Reza Skandari [...]

MDM Policy & Practice

Open accessResearch articleFirst published November 22, 2022

Glucose and Several Mitogenic Agents Modulate the Glucagon-Like Peptide-2 Receptor Expression in Cultured Rat Astrocytes

Esther Velázquez, Yannick Le Baut Ayuso, Enrique Blázquez [...]

Journal of Alzheimer's Disease Reports

Free accessResearch articleFirst published September, 2024

Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis

Maria-Ioanna Stefanou, Aikaterini Theodorou, Konark Malhotra [...]

European Stroke Journal